SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007395
Filing Date
2021-05-17
Accepted
2021-05-17 16:07:33
Documents
99
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20210331x10q.htm   iXBRL 10-Q 3080997
2 EX-10.1 fbio-20210331xex10d1.htm EX-10.1 833709
3 EX-10.2 fbio-20210331xex10d2.htm EX-10.2 433860
4 EX-10.3 fbio-20210331xex10d3.htm EX-10.3 591544
5 EX-31.1 fbio-20210331xex31d1.htm EX-31.1 13868
6 EX-31.2 fbio-20210331xex31d2.htm EX-31.2 14570
7 EX-32.1 fbio-20210331xex32d1.htm EX-32.1 8231
8 EX-32.2 fbio-20210331xex32d2.htm EX-32.2 8187
  Complete submission text file 0001558370-21-007395.txt   14611199

Data Files

Seq Description Document Type Size
9 EX-101.SCH fbio-20210331.xsd EX-101.SCH 92282
10 EX-101.CAL fbio-20210331_cal.xml EX-101.CAL 77849
11 EX-101.DEF fbio-20210331_def.xml EX-101.DEF 407113
12 EX-101.LAB fbio-20210331_lab.xml EX-101.LAB 596513
13 EX-101.PRE fbio-20210331_pre.xml EX-101.PRE 614092
14 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20210331x10q_htm.xml XML 2487054
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 21930504
SIC: 2834 Pharmaceutical Preparations